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The 2017–2018 North American influenza season caused more hospitalizations and deaths than any year since the 2009
H1N1 pandemic. The majority of recorded influenza infections were caused by A(H3N2) viruses, with most of the virus’s
North American diversity falling into the A2 clade. Within A2, we observe a subclade which we call A2/re that rose to com-
prise almost 70 per cent of A(H3N2) viruses circulating in North America by early 2018. Unlike most fast-growing clades,
however, A2/re contains no amino acid substitutions in the hemagglutinin (HA) segment. Moreover, hemagglutination
inhibition assays did not suggest substantial antigenic differences between A2/re viruses and viruses sampled during the
2016–2017 season. Rather, we observe that the A2/re clade was the result of a reassortment event that occurred in late 2016
or early 2017 and involved the combination of the HA and PB1 segments of an A2 virus with neuraminidase (NA) and other
segments a virus from the clade A1b. The success of this clade shows the need for antigenic analysis that targets NA in
addition to HA. Our results illustrate the potential for non-HA drivers of viral success and necessitate the need for more
thorough tracking of full viral genomes to better understand the dynamics of influenza epidemics.
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1. Introduction
Influenza virus epidemics cause significant morbidity and
mortality with about 10 per cent of the global population
infected annually (World Health Organization 2018) and
most recent mortality estimates indicate that there are
291,000–645,000 influenza virus-associated death each year
(Iuliano et al. 2018). Seasonality of influenza epidemics can
vary by geographic location. In temperate regions, influenza
activity typically peaks in mid-winter, while seasonal pat-
terns are less stereotypical in tropical or subtropical regions
(Petrova and Russell 2018). In addition, the severity of
Published by Oxford University Press 2019. This work is written by US Government employees and is in the public domain in the US.
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influenza epidemics can also vary by season and geography.
The 2017–2018 influenza season in the USA was the most se-
vere epidemic since the 2003–2004 season, resulting in 79,000
deaths and more than 330,000 hospitalizations in the USA
alone (Garten et al. 2018).
Throughout life humans are repeatedly infected by influenza
viruses, primarily due to antigenic drift wherein amino acid
substitutions in the hemagglutinin (HA) and/or neuraminidase
(NA) surface glycoproteins generate viruses that escape from
immunity induced by prior infection or vaccination. Out of the
four co-circulating lineages of epidemic influenza viruses,
A(H3N2) evolves the most rapidly, with generally higher circula-
tion levels, necessitating more frequent updates to the specific
strain used in the seasonal influenza vaccine (Hay et al. 2001;
Bedford et al. 2014). Due to ramifications in vaccine strain selec-
tion, improvements to tracking and predicting spread of
A(H3N2) variants presents an opportunity for scientific insights
to improve public health outcomes (Morris et al. 2017).
Research on influenza antigenic evolution focuses primarily
on HA, whose antigenic properties are historically analyzed
with hemagglutination inhibition (HI) assays (Hirst 1942).
Amino acid substitutions in epitope regions, primarily in the
globular head of the HA protein, alter antigenic phenotype of
the virus as measured by HI titers (Smith et al. 2004; Koel et al.
2013; Bedford et al. 2014; Neher et al. 2016). However, NA
evolves at nearly the same rate as HA and has similar signa-
tures of adaptive evolution (Bhatt, Holmes, and Pybus 2011). In
addition, recent work has shown the importance of anti-NA
antibodies to protective immunity through natural infection
and vaccination (Monto et al. 2015; Huang et al. 2018). This sug-
gests that NA evolution is a substantial contributor to the
changing antigenic properties and dynamics of influenza vi-
ruses. While most research is devoted to the study of antigenic
drift via specific amino acid substitutions, separate genomic
segments coding for HA and NA can reassort, allowing novel
genomic constellations to arise, a process that occurs fre-
quently in nature (Nelson et al. 2008; Marshall et al. 2013).
Reassortment can sometimes create novel adaptive genotypes
(Neverov et al. 2014; Dudas et al. 2015), but generally results in
deleterious, incompatible genotypes (Rabadan, Levine, and
Krasnitz 2008; Villa and La¨ssig 2017). In one notable example,
the spread of the Fujian/2002 antigenic variant was attributable
in part to reassortment between HA and other genomic seg-
ments, including NA (Holmes et al. 2005). The rapid develop-
ment of sequencing technology and specific strategies for
influenza virus genomics in the past decade enables sequenc-
ing of thousands of ‘full’ viral genomes annually, where each
genome consists of the coding sequences on each of the eight
influenza genome segments minus segment termini. Now,
nearly all influenza-positive surveillance specimens received
by the US Centers for Disease Control and Prevention are se-
quenced directly using a next-generation sequencing strategy
and submitted to the Global Initiative on Sharing All Influenza
Data (GISAID) EpiFlu database (Elbe and Buckland-Merrett
2017). Sequencing direct clinical samples avoids issues of virus
evolution during in vitro propagation. From this abundance of
genomic data, the dynamics of reassortment can be analyzed
at high temporal and genotypic resolution.
Here, we use tools from the Nextstrain project (Hadfield
et al. 2018) to show that a reassortant A(H3N2) genome con-
stellation dominated the 2017–2018 North American influ-
enza season. We go on to show that viruses with this
genome constellation had the HA and PB1 segments of one
parental virus with the other six segments of another virus,
and that the progenitor virus likely emerged in late 2016 or
early 2017.
2. Methods
2.1 Sequence and antigenic data
We built phylogenetic trees and frequency estimates for each
segment of the influenza virus genome containing data from a
2-year window between April 2016 and April 2018, as well as a
small set of older reference viruses. This window gives us
enough context to see global influenza diversity while main-
taining high resolution on the scale of months within individual
clades. A total of 18,844 A(H3N2) sequences were downloaded
from GISAID EpiFlu database with submission dates ranging be-
tween 15 April 2012 and 20 April 2018 (see Supplementary Text).
From these, sequences were subsampled to achieve equal
distribution of samples across geographic regions and over a
2-year window (see Supplementary Text TSV for full list of sam-
ples used in analysis). In addition to sampling evenly across
countries and time, subsampling prioritized virus strains for
which antigenic data were available and when possible there
were sequence data available for all genomic segments. In total,
1,862 sequences were used to construct phylogenetic trees. In
this analysis, we use antigenic data from focus reduction assays
provided by collaborating centers from the WHO Global
Influenza Surveillance and Response System.
2.2 Phylogenetic analysis
For each segment of the influenza virus genome, alignments
were created using MAFFT (Katoh and Standley 2013). Aligned
sequences were then cleaned of insertions relative to the refer-
ence to maintain consistent numbering of sites, and viruses
that deviate too much from the expected molecular clock were
removed. For each tree we included a set of reference viruses
that are well characterized (i.e. past vaccine strains) with sam-
pling dates before the 2-year window of interest. We then con-
structed phylogenetic trees using FastTree (Price, Dehal, and
Arkin 2009) according to the Jukes–Cantor model of nucleotide
evolution and a CAT model of site heterogeneity. After trees
were constructed, we refined them using RAxML (Stamatakis
2014). We inferred dates and ancestral sequences of each inter-
nal node of the trees (Sagulenko, Puller, and Neher 2018).
Finally, we annotated trees with attributes (i.e. geographic loca-
tion), and inferred these traits for ancestral nodes using
TreeTime. TreeTime (Sagulenko, Puller, and Neher 2018) imple-
ments a discrete trait phylogeographic analysis following
(Lemey et al. 2009). Viruses are assigned to ten broad geographic
regions and transition rates between these regions are estimat-
ing by maximizing likelihood of a CTMC model. Ancestral loca-
tions are estimated as the marginal distribution on ancestral
node states following this CTMC model.
2.3 Reassortment analysis
To detect reassortment, we constructed tangle trees—sets of
two trees representing different segments, with tips from
matching viruses connected by lines. We then compared topol-
ogies of tangle trees that matched the phylogeny of HA segment
with that of other segments. When incongruent tree topologies
were found, we compared whether the viruses labeled as A2
and A2/re in the HA phylogeny were adjacent in the other seg-
ment’s phylogeny, and if it appeared that A2/re was a subclade
of A2. If not, we inferred that a reassortment had taken place
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that combined the HA segment of an A2-like background with
the other segment from a separate background.
3. Results
3.1 Severe 2017–2018 North American influenza season
In many aspects the 2017–2018 North American influenza sea-
son was the most severe influenza epidemic in the past twelve
seasons, resulting in a large increase in visits for outpatient
influenza-like illness (ILI) (Fig. 1) and resulted in an estimated
960,000 hospitalizations and 79,000 influenza-associated
deaths, particularly among those sixty-five and older (Centers
for Disease Control and Prevention, 2018). In the USA, there
were over 23,000 confirmed cases of influenza A viruses be-
tween October 2017 and February 2018; of these 89.9 per cent
were A(H3N2) viruses. At the season’s peak, influenza A viruses
were responsible for 7.7 per cent of all hospitalizations and 10.1
per cent of deaths in the USA (Budd et al. 2018). The fraction of
health care visits for ILI surpassed those of the 2009 influenza
epidemic season (Fig. 1)—a season marked by the emergence of
the A(H1N1)pdm09 pandemic virus, that continues to cause an-
nual epidemics in humans (Garten et al. 2009). In addition to ris-
ing to high levels, the rate of hospital visits of symptoms of ILI
stayed above 4 per cent for 10 weeks during the 2017–2018
North American influenza season. Unusually, the North
American influenza season was disproportionally intense com-
pared to other global regions.
3.2 Genetic diversity of recent A(H3N2) viruses
Here, we analyze viral clades, representing clonal descendants
of a single common ancestor, on the HA segment of A(H3N2).
Rapid clade turnover results in an A(H3N2) HA phylogeny in
which contemporaneous viruses typically coalescence to a sin-
gle common ancestor within 3 years (Bedford et al. 2015).
However, the current most recent common ancestor (MRCA) of
the global A(H3N2) virus population, existed more than 6 years
ago in early 2012 (Fig. 2). Correspondingly, there is significant
genetic diversity among the HA segments of circulating viruses,
with the competing clades 3c3.A and 3c2.A comprising the
deepest split in the phylogeny. Descendants of the 3c3.A viruses
circulated at low frequencies in the global population between
2016 and 2018. Several HA subclades of 3c2.A, comprising
Figure 1. Percentage of health care visits for ILI in the US from the 1997–1998 to
the 2017–2018 season with season indicated by color. The 2017–2018 season is
highlighted as a thick line; it showed the highest ILI rate since the 2009 H1N1
pandemic virus. Data from Centers for Disease Control and Prevention, (2018).
Figure 2. Temporally resolved phylogenetic tree of recent A(H3N2) HA sequences. Shown are influenza viruses sampled between April 2016 and April 2018 colored by
clade designation (in addition, the tree shows a small number of earlier reference viruses). Viruses are subsampled to give comparable counts across time and geogra-
phy. HA segments of the majority of co-circulating A(H3N2) viruses in of the 2017–2018 Northern Hemisphere influenza season fell within clades A1b (top, yellow) or
A2 (center, orange). Vaccine viruses are indicated by cross marks.
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3c2.A1 to 3c2.A4, circulated at high frequencies between 2016
and 2018. Throughout the following, we drop the 3c2 to abbrevi-
ate these names to A1a, A1b, A2, A3, and A4. By April 2018, vi-
ruses in clades A1b and A2 predominated the global population,
comprising an estimated 86 per cent of A(H3N2) viruses (Fig. 2).
Clade A1 emerged in 2015 and represented the majority of
influenza A(H3N2) viruses in the 2016–2017 season. Most viruses
in this clade differ from the previous vaccine virus (A/Hong
Kong/4801/2014) by amino acid substitutions in HA (N121K,
N171K, I406V, and G484E). Clade A1 further diversified into two
subclades now named A1a and A1b. These are distinguished by
the amino acid substitutions HA:G479E and HA:K92R,H311Q, re-
spectively. Further rapid evolution took place within A1b which
split into two subclades defined by the HA amino acid substitu-
tions E62G, R142G, T135K, and T135N. In the past year A1b has
out-competed A1a.
Clade A2 is defined by a series of amino acid substitutions in
HA:T131K, R142K, R261Q. This series of substitutions completed
in mid-2016; no further amino acid changes were observed and
the frequency of this clade remained fairly constant from late
2016 to mid-2017 (Fig. 3). In the 2017–2018 season in North
America, however, an A2 HA subclade dominated the viruses
circulating, yet lacked additional amino acid substitutions. This
subclade—which we denote as A2/re (Fig. 2)—appears to have
arisen as a result of a reassortment event, as discussed below.
The rapid rise of subclade A2/re—coupled with an extraordi-
narily high incidence of that subclade in North America—
stands out. By the beginning of 2018, we find the clade viruses
belonging to clade A2 increasing to make up almost 70 per cent
of A(H3N2) circulating viruses, overtaking A1b as the dominant
HA clade (Fig. 3).
Across the entire HA phylogeny, we observe several sites
that undergo repeated nucleotide transitions. One example of
this is at site HA:160, which shows signatures of positive selec-
tion when analyzed by SLAC (Kosakovsky Pond and Frost 2005),
but this seems to be driven by frequent, unsuccessful muta-
tions, rather than ones that ultimately find success
(Supplementary Table S2 and Fig. S1). This presents an issue as
sites that undergo the same mutation throughout the tree and
show signatures of positive selection are often the result of pas-
saging adaptation, not to adaptations that arise within natural
viral circulation (Meyer and Wilke 2015; McWhite, Meyer, and
Wilke 2016). To circumvent this issue, we instead focus on
mutations that fix or rise to high frequency to determine adap-
tive origin.
3.3 Antigenic analysis illustrates little antigenic drift
The impact that the amino acid substitutions of the various co-
circulating HA clades have on antibody escape were analyzed
using postinfection ferret antisera against cell-propagated vi-
ruses including vaccine strains (Supplementary Table S1). The
recommended A(H3N2) vaccine viruses were A/Hong Kong/4801/
2014-like (i.e. A/Michigan/15/2014) for both the 2016–2017 and
the 2017–2018 Northern Hemisphere seasons. Focus reduction
assay of reference viruses and contemporary test viruses circu-
lating worldwide demonstrate that antisera to either HA clade
3c2.A A/Michigan/15/2014 virus or HA clade 3c2.A1 viruses A/
Singapore/INFIMH-16-0019/2016 efficiently neutralize viruses
expressing 3c2.A, A1, or A2 HA RNAs (Supplementary Table S1
and Fig. S2). In fact, only viruses expressing 3c3.A HAs, which
represent a small proportion of viruses circulating, showed evi-
dence of significant antigenic drift (i.e. 8-fold or greater reduc-
tions in titer as compared to titers of the homologous virus and
antisera) (Supplementary Table S1). Nevertheless, antisera to a
clade A2 virus (A/Nebraska/2/2017) efficiently neutralizes other
A2 viruses and poorly neutralizes viruses from other HA clades
(Supplementary Table S1 and Fig. S2). Collectively, antigenic
analysis data indicates that while the A2 HA proteins are anti-
genically distinct, they have not significantly drifted from 3c2.A
HA proteins and it does not explain their predominance in North
America during the 2017–2018 season. Consistently, substitu-
tions to epitope sites show that the A2 clade is slightly drifted
relative to ancestral 3c2.A viruses, but show little variation
within clade A2 (Supplementary Fig. S2).
3.4 Genome reassortment events among circulating
viruses leads to A2/re genotype
When reassortment occurs between viruses from established
clades in the HA and NA RNA segments, incongruent phyloge-
netic relationships are created so that a reassortment event
within clade A2 viruses is immediately visible (Fig. 4). In the HA
phylogeny, viruses from A2 and A2/re are closely related and
form a monophyletic clade. However in the NA phylogeny, the
NA of A2 viruses appear in a clade distant from the NA of A2/re
viruses. Viruses whose HA belongs to clade A2/re possess NA
with the N329S substitution which is shared with viruses that
belong to clade A1b. The NA segments of viruses belonging to
HA clade A2/re differ from viruses belonging to clade A2 by NA
substitutions I176M, K220N, N329S, D339N, and P386S.
Importantly, the amino acid substitution N329S is present in
the NA of viruses from both successful HA clades (A2/re and
A1b), as indicated by the local branch index which summarizes
recent clade growth (Supplementary Fig. S3) (Neher, Russell,
and Shraiman 2014). This reassortment was verified statistically
by use of GiRaF (Nagarajan and Kingsford 2011), which confirms
the strains present in the A2/re clade and those in the matched
NA clade as being part of a reassortment event (conf ¼ 0.99,
Supplementary Fig. S4).
Temporal phylogenetic analysis places the MRCA of the A2/
re genotype in the HA segment between December 2016 and
February 2017 (95% HPD 28 December 2016 to 11 February 2017)
and in the NA segment between January 2017 and March 2017
(95% HPD 24 January 2017 to 13 March 2017), suggesting that
most likely a reassortment event in January or February 2017
Figure 3. Frequency trajectories of A2 and A2/re clades partitioned by region. We
estimate frequencies of different clades based on sample counts and collection
dates. These estimates are based on all available data and global frequencies are
weighted according to regional population size and relative sampling intensity.
We use a Brownian motion process prior to smooth frequencies from month-to-
month (Neher and Bedford 2015). Transparent bands show an estimate the 95
per cent confidence interval based on sample counts.
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gave rise to a virus that seeded the rapidly growing population
with this genome constellation. We observe that viruses basal
to the reassortant A2/re clade in both HA and NA are predomi-
nantly from North and South America with A/Minnesota/12/
2017, collected in February 2017, representing an early example.
A discrete trait phylogeographic model places the root of the
A2/re reassortment event as 83 per cent North America/17 per
cent South America (HA) and 100 per cent North America (NA).
To quantify the rise of A2/re, we examined two mutations—
one in HA and one in NA—that combine to identify the beginning
of the reassortant constellation. The presence of all four pairwise
combinations of these two mutation states indicates that a reas-
sortment event has occurred, as only three states can arise in the
absence of reassortment. In the HA phylogeny we use the muta-
tion HA:T131K, and in NA we use NA:N329S. In our data, the
three non-reassortant genotypes were observed at frequencies
around 10–20 per cent in 2016, but the A2/re genotype first
appeared in February 2017. By December 2017, this genotype had
risen to above 70 per cent frequency in North America; this is a
comparable rate to that at which the 3c3 clade rose to predomi-
nance during 2012–2013 (Fig. 4). For this analysis, we use only
HA:T131K as an identifying mutation for the derived clade,
though we can find the same results through using HA1 sites 142
and 261 as all three can be used to define the transition from the
ancestral state of HA—in our case the split of A2 from A1.
The HA phylogeny for A2/re viruses are also incongruent com-
pared to A2 viruses within trees for the six other RNA segments
(PB2, PA, NP, NA, MP, NS). As with the NA, the six other RNA
segments of A2/re viruses are most closely related to those of HA
clade A1b containing viruses (Supplementary Fig. S5).
Phylogenetic analysis of the PB1 shows that viruses from the reas-
sortant clade A2/re are adjacent to A2 viruses (Supplementary Fig.
S5). Upon examining all other segments for incongruent phyloge-
nies, we find evidence that the A2/re genotype is the result of reas-
sortment events pairing HA and PB1 segments from A2 viruses
with all other segments from A1b viruses (Fig. 5).
4. Discussion
Most A(H3N2) influenza viruses that circulated during the 2017–
2018 season in North America had hemagglutinin consensus
sequences that were very similar to those of to A2 viruses,
which also circulated during the previous 2016–2017 season.
Consistently, antigenic analysis did not suggest significant anti-
genic evolution among these viruses. Only genomic sequencing
and analysis of all viral RNA segments revealed that recent A2
viruses differ substantially in six of the eight RNA segments.
This new genotype which we call A2/re is likely the result of a
single reassortment event that took place in late 2016 or early
2017. This reassortant genotype combines the HA and PB1 seg-
ments of A2-like viruses with all other segments from an A1b-
like virus. Viruses with the A2/re genotype quickly rose to high
frequency within North America, coincident with one of the
most severe influenza virus epidemics in recent years. During
the 2018 influenza vaccine selection for the Southern
Hemisphere’s 2019 season A/Switzerland/8060/2017, an A2/re
Figure 4. (Top) Reassortment combines existing genetic diversity and results in incongruent phylogenetic trees. The figure shows time-scaled phylogenetic trees of HA
(left) and NA (right) colored genotype at HA site 131 and NA site 329. The HA and NA sequences from the virus isolates are connected by lines. We see that the closest
relatives for the viruses belonging to A2/re genotype (red) in HA are A2 viruses (blue), while their closest relatives in NA are A1 viruses (purple). (Bottom) Global esti-
mated frequency plots of virus clades over time. There is moderate growth of A1 viruses prior to the reassortment, but after the reassortment takes place we observe
rapid growth of the reassortant clade to approximately 70 per cent frequency. Branches on the HA tree are labeled by HA clade designation; branches on the NA tree
are labeled by NA amino acid substitution. Vaccine strains are indicated by cross marks.
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virus, was selected as the A(H3N2) component of the vaccine
(World Health Organization 2017).
While HA antigenic properties are well characterized across
A(H3N2) viruses, antigenic characteristics of NA are not as well
understood. The NA protein of these viruses differs from the
previous A2 NA viruses at several positions including position
329. Position 329 changed repeatedly over the past few years
and substitutions at this site could result in a loss of N-linked
glycosylation. The N329S clade rose rapidly in prevalence prior
to the reassortment event that gave rise to A2/re, supporting
the hypothesis that the genomic background including the NA
segment acquired in the reassortment event aided the success
of A2/re viruses. In addition, the NA acquired two
substitutions—I176M and P386S—prior to the reassortment
event. Further data are required to understand the full effect of
these substitutions on NA antigenicity, both within the A2/re vi-
ruses and other genotypes. In addition to antigenic effects, rep-
lication capacity of the virus depends on interactions between
different segments and their stoichiometry, as has been demon-
strated for different HA and NA variants (Yen et al. 2011).
While it is clear that there was rapid expansion/dissemination
of A2/re genotype viruses, we cannot at this time show
evidence that this clade’s success was solely the result of
the reassortment event. Reassortment is relatively common in in-
fluenza virus evolution (Holmes et al. 2005; Nelson et al. 2008).
Hence assigning significance to any specific reassortment event is
difficult and the rapid growth of the A2/re genotype might also be
driven by other epidemiological factors. We also cannot be sure of
the geographic origin of this reassortant virus. Our subsampling
method samples evenly through time and geography—thereby
minimizing geographic bias. However, we cannot be certain of the
exact geographic origin of the reassortment prior to its rise to
prominence within North America.
The capacity of influenza viruses to spread likely depends
on the specific genome constellation of all eight RNA segments.
Hence it is important to systematically survey viral evolution
and reassortments of influenza viruses by genomic sequencing
and a comprehensive analysis of these data. Retrospective
analysis of historical data should be conducted to quantify the
degree to which reassortment events give rise to successful gen-
otypes (Nelson et al. 2008; Dudas et al. 2015; Villa and La¨ssig
2017). Results from such analysis can then inform predictive
modeling efforts to anticipate composition of future influenza
virus populations (Łuksza and La¨ssig 2014; Neher, Russell, and
Shraiman 2014; Morris et al. 2017; Klingen et al. 2018). In addi-
tion to paramount importance for public health, the wealth of
genomic longitudinal data with high spatiotemporal resolution
make influenza viruses an ideal system to address general
questions of evolutionary biology on epistasis, reassortment,
and recombination.
The inclusion of genomic predictors that draw information
from all eight RNA segments into fitness models will
yield more robust prediction methodologies that account for
more than just HA variance. We believe that integrating
these sources of information into models of influenza evolu-
tion will help to predict future influenza genotype growth.
Furthermore, it would aid mitigating the effect of future influ-
enza outbreaks that would otherwise pose great risk to global
human health.
Supplementary Data
Supplementary data are available at Virus Evolution online.
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